113 related articles for article (PubMed ID: 18827376)
1. Quality of twelve clarithromycin dry syrup formulations-bitterness, grittiness and uniformity of drug loading.
Ishizaka T; Okada S; Tokuyama E; Mukai J; Uchida T
Chem Pharm Bull (Tokyo); 2008 Oct; 56(10):1389-94. PubMed ID: 18827376
[TBL] [Abstract][Full Text] [Related]
2. The bitterness intensity of clarithromycin evaluated by a taste sensor.
Tanigake A; Miyanaga Y; Nakamura T; Tsuji E; Matsuyama K; Kunitomo M; Uchida T
Chem Pharm Bull (Tokyo); 2003 Nov; 51(11):1241-5. PubMed ID: 14600366
[TBL] [Abstract][Full Text] [Related]
3. The suppression of enhanced bitterness intensity of macrolide dry syrup mixed with an acidic powder.
Ishizaka T; Okada S; Takemoto E; Tokuyama E; Tsuji E; Mukai J; Uchida T
Chem Pharm Bull (Tokyo); 2007 Oct; 55(10):1452-7. PubMed ID: 17917288
[TBL] [Abstract][Full Text] [Related]
4. [Bitterness of the mixture of clarithromycin dry syrup and carbocisteine preparation--difference between brand name and generic drugs].
Matsuo R; Tanaka S; Kanou M; Isono K; Tanaka Y; Taura T; Asada Y; Akamine Y; Sawai H; Kinosita M; Sudou T; Kunoki Y; Miki A; Hori S; Satoh H; Ohtani H; Sawada Y
Yakugaku Zasshi; 2008 Mar; 128(3):479-85. PubMed ID: 18311069
[TBL] [Abstract][Full Text] [Related]
5. Bitterness evaluation of medicines for pediatric use by a taste sensor.
Ishizaka T; Miyanaga Y; Mukai J; Asaka K; Nakai Y; Tsuji E; Uchida T
Chem Pharm Bull (Tokyo); 2004 Aug; 52(8):943-8. PubMed ID: 15304986
[TBL] [Abstract][Full Text] [Related]
6. Method of evaluation of the bitterness of clarithromycin dry syrup.
Yajima T; Fukushima Y; Itai S; Kawashima Y
Chem Pharm Bull (Tokyo); 2002 Feb; 50(2):147-52. PubMed ID: 11848199
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of bitterness suppression of macrolide dry syrups by jellies.
Tsuji E; Uchida T; Fukui A; Fujii R; Sunada H
Chem Pharm Bull (Tokyo); 2006 Mar; 54(3):310-4. PubMed ID: 16508183
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the bitterness of antibiotics using a taste sensor.
Uchida T; Tanigake A; Miyanaga Y; Matsuyama K; Kunitomo M; Kobayashi Y; Ikezaki H; Taniguchi A
J Pharm Pharmacol; 2003 Nov; 55(11):1479-85. PubMed ID: 14713358
[TBL] [Abstract][Full Text] [Related]
9. Microencapsulation of erythromycin and clarithromycin using a spray-drying technique.
Zgoulli S; Grek V; Barre G; Goffinet G; Thonart P; Zinner S
J Microencapsul; 1999; 16(5):565-71. PubMed ID: 10499837
[TBL] [Abstract][Full Text] [Related]
10. Impact of uncharged and charged stabilizers on in vitro drug performances of clarithromycin nanocrystals.
Soisuwan S; Teeranachaideekul V; Wongrakpanich A; Langguth P; Junyaprasert VB
Eur J Pharm Biopharm; 2019 Apr; 137():68-76. PubMed ID: 30769087
[TBL] [Abstract][Full Text] [Related]
11. Formulation and evaluation of less-painful clarithromycin lipid microspheres.
LingHao Q; Wei L
Arch Pharm Res; 2007 Oct; 30(10):1336-43. PubMed ID: 18038913
[TBL] [Abstract][Full Text] [Related]
12. Famotidine orally disintegrating tablets: bitterness comparison of original and generic products.
Tokuyama E; Matsunaga C; Yoshida K; Mifsud JC; Irie T; Yoshida M; Uchida T
Chem Pharm Bull (Tokyo); 2009 Apr; 57(4):382-7. PubMed ID: 19336932
[TBL] [Abstract][Full Text] [Related]
13. Clarithromycin-loaded liposomes offering high drug loading and less irritation.
Liu X; Sun W; Zhang B; Tian B; Tang X; Qi N; He H; Li H; Jin X
Int J Pharm; 2013 Feb; 443(1-2):318-27. PubMed ID: 23337631
[TBL] [Abstract][Full Text] [Related]
14. A survey of the quality of generic clarithromycin products manufactured in Slovenia and Israel.
Nightingale CH
Adv Ther; 2000; 17(3):167-78. PubMed ID: 11183454
[TBL] [Abstract][Full Text] [Related]
15. Bitterness-Masking Effects of Different Beverages on Zopiclone and Eszopiclone Tablets.
Yoshida M; Kojima H; Uda A; Haraguchi T; Ozeki M; Kawasaki I; Yamamoto K; Yano I; Hirai M; Uchida T
Chem Pharm Bull (Tokyo); 2019; 67(5):404-409. PubMed ID: 31061364
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics.
Lou H; Liu M; Qu W; Hu Z; Brunson E; Johnson J; Almoazen H
Drug Dev Ind Pharm; 2014 Jul; 40(7):910-8. PubMed ID: 23621768
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of palatability of 10 commercial amlodipine orally disintegrating tablets by gustatory sensation testing, OD-mate as a new disintegration apparatus and the artificial taste sensor.
Uchida T; Yoshida M; Hazekawa M; Haraguchi T; Furuno H; Teraoka M; Ikezaki H
J Pharm Pharmacol; 2013 Sep; 65(9):1312-20. PubMed ID: 23927469
[TBL] [Abstract][Full Text] [Related]
18. Development of a predictive in vitro dissolution for clarithromycin granular suspension based on in vitro-in vivo correlations.
Alkhalidi BA; Al-Ghazawi M; AlKhatib HS; Sallam A
Pharm Dev Technol; 2010 Jun; 15(3):286-95. PubMed ID: 22716469
[TBL] [Abstract][Full Text] [Related]
19. Optimum heat treatment conditions for masking the bitterness of the clarithromycin wax matrix.
Yajima T; Itai S; Takeuchi H; Kawashima Y
Chem Pharm Bull (Tokyo); 2003 Nov; 51(11):1223-6. PubMed ID: 14600362
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting the bitterness intensities of ten commercial formulations of ambroxol.
Uchida T; Sugino Y; Hazekawa M; Yoshida M; Haraguchi T
Chem Pharm Bull (Tokyo); 2012; 60(8):949-54. PubMed ID: 22863696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
